Nothing Special   »   [go: up one dir, main page]

Andersson et al., 1981 - Google Patents

Hyperoxaluria in malabsorptive states

Andersson et al., 1981

Document ID
11054178057999276547
Author
Andersson H
Bosaeus I
Publication year
Publication venue
Urologia Internationalis

External Links

Snippet

During the last 10 years it has become apparent that hyperoxaluria often is present in malabsorptive states. This secondary hyperoxaluria could be explained by an increased uptake of dietary oxalate due to malabsorption of fatty acids and bile salts. Dietary …
Continue reading at karger.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Nightingale Management of patients with a short bowel
Nightingale et al. Guidelines for management of patients with a short bowel
Jeejeebhoy Short bowel syndrome: a nutritional and medical approach
Smith et al. Gastric acid secretion and vitamin B12 absorption after vertical Rouxen-Y gastric bypass for morbid obesity
Meier et al. Nutrition in pancreatic diseases
Zhu et al. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective
Andersson et al. Hyperoxaluria in malabsorptive states
Buchman Etiology and initial management of short bowel syndrome
Scolapio et al. SHORT BOWEL SYNDROME
JP2019194212A (en) Method of treating chronic kidney disease
Santoro et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases
Younes et al. Fermentable carbohydrate supplementation alters nitrogen excretion in chronic renal failure
Mole et al. Renal complications of jejuno‐ileal bypass for obesity
Baker et al. Nutritional considerations after gastrectomy and esophagectomy for malignancy
Emmett et al. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome
Stone et al. L-thyroxine absorption in patients with short bowel
Gjessing et al. Energy intake, nutritional status and weight reduction in patients one year after laparoscopic sleeve gastrectomy
Shirai et al. The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients—multicenter trial
Hofmann et al. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery: Oxalogenic substances in diet contribute to urinary oxalate
Nightingale The short-bowel syndrome
DOUER et al. Neisseria catarrhalis endocarditis
Takei et al. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria
Gong et al. Role of enteral nutrition in adult short bowel syndrome undergoing intestinal rehabilitation: the long-term outcome
ELSAS et al. Cholecystocolonic fistula with malabsorption
Grant et al. Invited Review: Malabsorption associated with surgical procedures and its treatment